SCD — Zentiva SA Income Statement
0.000.00%
HealthcareBalancedMicro Cap
Annual income statement for Zentiva SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 558 | 711 | 760 | 954 | 1,114 |
| Cost of Revenue | |||||
| Gross Profit | 276 | 393 | 404 | 494 | 637 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 485 | 595 | 673 | 769 | 864 |
| Operating Profit | 73.3 | 116 | 86.3 | 185 | 250 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 80.5 | 119 | 115 | 222 | 288 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 65.6 | 106 | 99.5 | 193 | 251 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 65.6 | 106 | 99.5 | 193 | 251 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 65.6 | 106 | 99.5 | 193 | 251 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.098 | 0.156 | 0.147 | 0.277 | 0.362 |
| Dividends per Share |